New IgM and IgG antibody assays will help indicate whether a person potentially developed immunity against the coronavirus (SARS-CoV-2) In response to the global COVID-19 pandemic, Beckman Coulter announce that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems...
In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators....
ACD/Labs and Nanalysis Scientific Corp. are pleased to announce that they have entered into a collaborative arrangement that will supply Nanalysis 60 and 100 MHz benchtop NMR spectrometer purchasers with ACD/Spectrus Processor software for data processing and analysis. The announcement was made at the 61st Experimental Nuclear Magnetic Resonance Conference (ENC) that brings spectroscopists from all over the world together to discuss innovations...
Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer’s RT-PCR test is marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in over 30 countries worldwide....
Ziath Ltd. has received orders for its DataPaq™ Mirage Rack Scanner from a growing number of laboratories that specialise in testing patient samples for Coronavirus Covid-19 infection. Stephen Knight, Director of Sales & Marketing at Ziath Ltd commented "The Coronavirus Covid-19 pandemic has sadly already claimed the lives of over 20,000 people worldwide. The World Health Organisation has stated that widespread testing of people for Coronavirus Covid-19 will help health services identify infected patients...
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials....
The Francis Crick Institute, the UK’s largest discovery biomedical research lab, has offered to support the Government’s efforts to tackle the spread of COVID-19. In communications with Government Chief Scientific Adviser, Sir Patrick Vallance, the Crick’s extensive scientific resources and expertise have been offered to assist in the Government’s fight against the Coronavirus pandemic by helping to increase the number of tests that can be conducted by Public Health England and the NHS....
Test will now be available for qualified laboratories across the European Union. Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19. "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens....
After almost 40 years as managing director of FRITSCH GmbH, Robert Fritsch was bid farewell on his retirement on 1st January 2020. He looks back on times of modernization, economic growth and success. In 1920 the medium-sized family business was fund in Idar-Oberstein as a technical precious stones dealer by Max and Alfred Fritsch. After the Second World War Willi and Paul Fritsch, sons of Alfred Fritsch, took over the management....
Avonchem’s clinically proven COVID-19 IgG/IgM Rapid Test is designed for initial screening by detecting anti-SARS-CoV-2 IgG and IgM antibodies in either human serum, plasma or whole blood within just 15 minutes. This test is easy-to-use, requires only minimally skilled personnel with basic equipment needs. This COVID-19 IgG/IgM Rapid Test has >94% sensitivity and 100% specificity making it one of the most effective screening tests for COVID-19...
Scientific Laboratory Supplies (SLS) and the Science Council have announced the cancellation of the Scientific Laboratory Show and Conference which was due to take place on May 20th 2020 at the East Midlands Conference Centre Nottingham. The UK’s biggest laboratory show and conference was expected to attract well over 1400 visitors plus over 70 exhibitors, Science Council member bodies and SLS personnel. After careful consultation and considering the development of the virus in the UK and Europe it was decided to cancel the event.....
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, has announced that it has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention and research funding package. The funding will be used by Mologic and global partners, to develop a point-of-need diagnostic test for the virus...
Due to the circumstances related to the COVID-19 epidemic and in the context of the French government’s decision of 29 February relating to the public gatherings in France in order to contain his spread, Reed Expositions France and the CIFL have decided to postpone the holding of Forum LABO LYON (initially scheduled for 25 and 26 March 2020) to 7 and 8 October 2020 at the Eurexpo Lyon Exhibition Centre. This decision, difficult to make, is the most reasonable....
Merck, a leading science and technology company, has announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits. The kits analyze metabolites deregulated in several cancer types, making diagnoses more accurate. “Both small and large diagnostic and clinical testing kit manufacturers struggle to find high quality, reliable contract manufacturing organizations like us,” said Jean-Charles Wirth, head of Applied Solutions, Life Science, at Merck....
Under the non-exclusive agreement, GE Healthcare Life Sciences will manufacture RevoluGen's Fire Monkey / Fire Flower product. The Fire Monkey / Fire Flower kit uses spin columns to both extract High Molecular Weight DNA with an average length of 100 kb or more from animal and bacterial cells and to remove the fragments of DNA smaller than 10 kb. The longer the DNA that can be extracted intact, the better any subsequent long genomic sequencing reads can be....
TTP plc (TTP), a leading independent technology and product development company, and DiaSorin, a global leader in the in vitro diagnostic (IVD) field, have signed an exclusive licence and technology transfer agreement. DiaSorin will combine its extensive molecular test offering with TTP’s Puckdx™ platform to develop a single-use, sample-to-answer, molecular diagnostics point-of-care platform for human IVD applications....
The organisers have decided to postpone ARABLAB+ 2020 due to the overwhelming concerns of a majority of exhibitors, visitors, principals and agents who normally attend the event over their ability to travel to the Show, and the Health & Welfare of their staff. They felt that they could not guarantee a successful exhibition with the number and quality of visitors that our exhibitors have normally come to expect.
Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies, have announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the closing price of QIAGEN's common stock on the Frankfurt Prime Standard on March 2, 2020...
Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by professors Maria Makrides and Robert Gibson. Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson, and recently appointed Mr Marco Baccanti as CEO....
Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows...
New IgM and IgG antibody assays will help indicate whether a person potentially developed immunity against the coronavirus (SARS-CoV-2) In response to the global COVID-19 pandemic, Beckman Coulter announce that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems...
In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators....
ACD/Labs and Nanalysis Scientific Corp. are pleased to announce that they have entered into a collaborative arrangement that will supply Nanalysis 60 and 100 MHz benchtop NMR spectrometer purchasers with ACD/Spectrus Processor software for data processing and analysis. The announcement was made at the 61st Experimental Nuclear Magnetic Resonance Conference (ENC) that brings spectroscopists from all over the world together to discuss innovations...
Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer’s RT-PCR test is marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in over 30 countries worldwide....
Ziath Ltd. has received orders for its DataPaq™ Mirage Rack Scanner from a growing number of laboratories that specialise in testing patient samples for Coronavirus Covid-19 infection. Stephen Knight, Director of Sales & Marketing at Ziath Ltd commented "The Coronavirus Covid-19 pandemic has sadly already claimed the lives of over 20,000 people worldwide. The World Health Organisation has stated that widespread testing of people for Coronavirus Covid-19 will help health services identify infected patients...
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials....
The Francis Crick Institute, the UK’s largest discovery biomedical research lab, has offered to support the Government’s efforts to tackle the spread of COVID-19. In communications with Government Chief Scientific Adviser, Sir Patrick Vallance, the Crick’s extensive scientific resources and expertise have been offered to assist in the Government’s fight against the Coronavirus pandemic by helping to increase the number of tests that can be conducted by Public Health England and the NHS....
Test will now be available for qualified laboratories across the European Union. Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19. "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens....
After almost 40 years as managing director of FRITSCH GmbH, Robert Fritsch was bid farewell on his retirement on 1st January 2020. He looks back on times of modernization, economic growth and success. 
Avonchem’s clinically proven COVID-19 IgG/IgM Rapid Test is designed for initial screening by detecting anti-SARS-CoV-2 IgG and IgM antibodies in either human serum, plasma or whole blood within just 15 minutes. This test is easy-to-use, requires only minimally skilled personnel with basic equipment needs. This COVID-19 IgG/IgM Rapid Test has >94% sensitivity and 100% specificity making it one of the most effective screening tests for COVID-19...
Scientific Laboratory Supplies (SLS) and the Science Council have announced the cancellation of the Scientific Laboratory Show and Conference which was due to take place on May 20th 2020 at the East Midlands Conference Centre Nottingham. The UK’s biggest laboratory show and conference was expected to attract well over 1400 visitors plus over 70 exhibitors, Science Council member bodies and SLS personnel. After careful consultation and considering the development of the virus in the UK and Europe it was decided to cancel the event.....
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, has announced that it has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention and research funding package. The funding will be used by Mologic and global partners, to develop a point-of-need diagnostic test for the virus...
Due to the circumstances related to the COVID-19 epidemic and in the context of the French government’s decision of 29 February relating to the public gatherings in France in order to contain his spread, Reed Expositions France and the CIFL have decided to postpone the holding of Forum LABO LYON (initially scheduled for 25 and 26 March 2020) to 7 and 8 October 2020 at the Eurexpo Lyon Exhibition Centre. This decision, difficult to make, is the most reasonable....
Merck, a leading science and technology company, has announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits. The kits analyze metabolites deregulated in several cancer types, making diagnoses more accurate. “Both small and large diagnostic and clinical testing kit manufacturers struggle to find high quality, reliable contract manufacturing organizations like us,” said Jean-Charles Wirth, head of Applied Solutions, Life Science, at Merck....
Under the non-exclusive agreement, GE Healthcare Life Sciences will manufacture RevoluGen's Fire Monkey / Fire Flower product. The Fire Monkey / Fire Flower kit uses spin columns to both extract High Molecular Weight DNA with an average length of 100 kb or more from animal and bacterial cells and to remove the fragments of DNA smaller than 10 kb. The longer the DNA that can be extracted intact, the better any subsequent long genomic sequencing reads can be....
TTP plc (TTP), a leading independent technology and product development company, and DiaSorin, a global leader in the in vitro diagnostic (IVD) field, have signed an exclusive licence and technology transfer agreement. DiaSorin will combine its extensive molecular test offering with TTP’s Puckdx™ platform to develop a single-use, sample-to-answer, molecular diagnostics point-of-care platform for human IVD applications....
The organisers have decided to postpone ARABLAB+ 2020 due to the overwhelming concerns of a majority of exhibitors, visitors, principals and agents who normally attend the event over their ability to travel to the Show, and the Health & Welfare of their staff. They felt that they could not guarantee a successful exhibition with the number and quality of visitors that our exhibitors have normally come to expect.
Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies, have announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the closing price of QIAGEN's common stock on the Frankfurt Prime Standard on March 2, 2020...
Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by professors Maria Makrides and Robert Gibson. Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson, and recently appointed Mr Marco Baccanti as CEO....
Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows...